Hutch News

Results per Page: 20
  • 5
  • 10
  • 20
  • 50
  • 100

Fred Hutch adds senior leaders from Celgene and Amazon to board of trustees

Dr. Corsee Sanders and Sean Boyle add science, technology, finance and innovation expertise to cancer research center’s board
Releases - July 09, 2019

DeFeatHIV receives second five-year grant from NIH to research gene and cell therapies

The funding allows Fred Hutch’s HIV cure program to both extend and expand
Releases - July 13, 2016

Many immunotherapy trial participants with blood cancer in remission, preliminary results show

High rates of complete remission reported in patients with advanced blood cancers in preliminary results from ongoing immunotherapy trial
Hutch News - December 07, 2015

'A tidal wave coming': Xconomy Forum focuses on promising treatments

Immunotherapy a key topic at sold-out discussion on the role of biotech in Seattle
Hutch News - May 07, 2015

Three cancer research powerhouses form immunotherapy startup

Fred Hutch, Memorial Sloan-Kettering and Seattle Children’s Research Institute join to launch Juno Therapeutics
Hutch News - December 03, 2013
Last Modified, August 15, 2019